Additionally, this analysis identified that CD68+ TAMs tend to cluster with tumor cells and away from stromal cells, while CD163+ and CD206+ TAMs tend to cluster with stromal cells and away from tumor cells (Fig 3B). The gene discussed is CD163; the disease is neoplasm.